The Role of the Pulmonary Vascular Microenvironment in Chronic Thromboembolic Pulmonary Hypertension
Open Access
- 1 July 2025
- journal article
- review article
- Published by Wiley in Pulmonary Circulation
- Vol. 15 (3) , e70118
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by persistent obstruction and vascular remodeling of the pulmonary arteries following pulmonary thromboembolism (PTE), diagnosed after a minimum of 3 months of therapeutic anticoagulation. Disease progression from PTE to CTEPH takes place in the pulmonary circulation, where the vascular microenvironment is composed of a fluid portion that includes blood cells and components of the fibrinolytic system, and various vascular cells, including endothelial and smooth muscle cells. Following PTE, the homeostasis of the pulmonary vascular microenvironment is disrupted, leading to the accumulation of inflammatory mediators and immune cells at the site of thrombosis. Platelets are also involved in the regulation of coagulation and inflammation, and functional changes such as impaired fibrinolysis are observed. Subsequently, endothelial cell dysfunction and smooth muscle cell dysregulation lead to delayed thrombus resolution and pulmonary vascular remodeling, eventually resulting in CTEPH. Early intervention targeting the aberrant vascular microenvironment may thwart or mitigate the transition from PTE to CTEPH. Here, we discuss the development of CTEPH from the perspective of the pulmonary vascular microenvironment and examine its related biomarkers and therapeutic methods for CTEPH diagnosis and treatment.Keywords
This publication has 139 references indexed in Scilit:
- Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expressionAmerican Journal of Physiology-Cell Physiology, 1999
- Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo AngiogenesisScience, 1997
- Nitric Oxide Reversibly Inhibits the Migration of Cultured Vascular Smooth Muscle CellsCirculation Research, 1996
- Pathology of Pulmonary ThromboembolismChest, 1995
- The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosisNature Medicine, 1995
- Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli.Circulation, 1994
- Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.Circulation, 1994
- Levels of plasma thrombomodulin are increased in atheromatous arterial diseaseThrombosis Research, 1993
- Nitric oxide: an endogenous modulator of leukocyte adhesion.Proceedings of the National Academy of Sciences of the United States of America, 1991
- One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodiesClinica Chimica Acta, 1990